// App-Quantinova.ai

2438 : Does a Change in IPSS-R between Diagnosis and Transplant Have an Impact on Transplant Outcome in Patients with MDS? a Retrospective Analysis from the EBMT Chronic Malignancies Working Party

Researchers

Presenter

  • Christof Scheid

Principal Investigators

  • Riitta Niittyvuopio

  • Johan Maertens

  • Jakob Passweg

  • Didier Blaise

  • Jennifer Byrne

  • Nicolaus Krger

  • Martin Bornhuser

  • Patrice Chevallier

  • Jean-Henri Bourhis

  • Jan J. Cornelissen

  • Henrik Sengeloev

  • Jrgen Finke Sr

  • John A Snowden

  • Tobias Gedde-Dahl

  • Denis Guyotat

  • Urs Schanz

  • Amit Patel

  • Linda Koster

  • Liesbeth C. de Wreede

  • Patrick J Hayden

  • Francesco Onida

  • Marie Robin

  • Ibrahim Yakoub-Agha

Medical Centers

  • Department 1 for Internal Medicine, Center for Integrated Oncology Koln-Bonn, University Hospital Cologne, Cologne, Germany

  • EBMT Data Office Leiden, Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, Netherlands

  • Helsinki Hospital, HELSINKI, FIN

  • University Hospital Gasthuisberg, Leuven, Belgium

  • Haematology, University Hospital, Basel, Switzerland

  • Institut Paoli-Calmettes, Marseille, France

  • Centre for Clinical Haematology, Nottingham University Hospital, Nottingham, United Kingdom

  • University Hospital Eppendorf Frauenklinik, Hamburg, Germany

  • University Cancer Center, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany

  • Hematology Clinic, CHU Nantes, Nantes, France

  • Gustave Roussy, Villejuif, France

  • Department of Hematology, Erasmus MC Cancer Insitute, Rotterdam, Netherlands

  • Rigshospitalet, Copenhagen, Denmark

  • University of Freiburg, Freiburg, Germany, Dept. of Hematology, Oncology and Stem Cell Transplantation,, Freiburg, Germany

  • Department of Histopathology, Leeds Teaching Hospitals NHS Foundation Trust, Leeds, United Kingdom

  • Department ofHaematology, Oslo University Hospital and Instituteof Clinical Medicine University of Oslo, Oslo,Norway

  • Hematology department, Lucien Neuwirth Cancer Institute, Saint-Priest-en-Jarez, France

  • The Christie NHS Foundation Trust (retired), Manchester, United Kingdom

  • LUMC, Dept. Medical Statistics & Bioinformatics, Leiden, Netherlands

  • Department of Histopathology, St. James's Hospital, Dublin, Ireland

  • BMT Center - Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - University of Milan, Milano, Italy

  • Hospital Saint Antoine, Paris, France

  • Univ Lille, CHU de Lille, INFINITE, INSERM U1286, 59000 Lille, LILLE, France

Locations

  • Germany

  • Netherlands

  • Belgium

  • Switzerland

  • France

  • United Kingdom

  • Denmark

  • Norway

  • Ireland

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved